Table 2 Clinical characteristics
Patients No | Sex/Age (y) | Previous treatment | Response to FCR | Response to RIT | Follow up (mo) since RIT |
|---|---|---|---|---|---|
1 | F/68 | CHOP/R, radiotherapy | CR | CR | 50 alive in CR |
2 | F/66 | Radiotherapy, CHOP/R | CR | CR | 34 alive in CR |
3 | F/57 | CHOP/R | PR | CR | 44 alive in CR |
4 | F/67 | CHOP/R, radiotherapy | CR | CR | 13 dead in CR |
5 | M/46 | CHOP/like, ASCT, IFN maintenance for 24 months | PR | CR | 28 alive in CR |
6 | F/61 | MACOPB/R | CR | CR | 39 alive in CR |
7 | M/69 | CHOP,FM/R, Cy Dex/R | CR | CR | 30 dead in CR |
8 | M/57 | Chlorambucil, MACOPB/R | CR | CR | (t-MDS) 32 dead in CR |
9 | F/77 | Chlorambucil, radiotherapy | CR | CR | 44 alive in CR |